A detailed history of Diadema Partners LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Diadema Partners LP holds 24,618 shares of NVO stock, worth $1.63 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
24,618
Holding current value
$1.63 Million
% of portfolio
0.44%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$69.3 - $90.95 $1.71 Million - $2.24 Million
24,618 New
24,618 $1.68 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $149B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Diadema Partners LP Portfolio

Follow Diadema Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diadema Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Diadema Partners LP with notifications on news.